Inventor
MALLET FRANCOIS
FR27 patents
⚠️ This page may combine multiple inventors who share the name “MALLET FRANCOIS”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
BIO MERIEUX
15 patentsUS5874260AFeb 23, 1999
Oligonucleotide which can be used as primer in a method of amplification based on a replication accompanied by strand displacement
BIO MERIEUX158 citations97
US5849547ADec 15, 1998
Method for nucleic acid amplification by transcription using displacement, and reagents and kit therefor
BIO MERIEUX266 citations97
US6342383B1Jan 29, 2002
Cell lines and viral isolates associated with multiple sclerosis
BIO MERIEUX34 citations96
US5744308AApr 28, 1998
Chimera oligonucleotide and its utilization for obtaining transcripts of a nucleic acid
BIO MERIEUX116 citations96
US6218151B1Apr 17, 2001
Method for nucleic acid amplification by transcription using displacement, and reagents and kit therefor
BIO MERIEUX79 citations95
US5800980ASep 1, 1998
Detection of MSRV1 virus and MSRV2 pathogen and/or infective agent associated with multiple sclerosis, by nucleic acid hybridization
BIO MERIEUX17 citations92
US5891681AApr 6, 1999
Modified promoter for RNA polymerase, its preparation and its applications
BIO MERIEUX35 citations91
US6632615B2Oct 14, 2003
Method for isolating a target biological material, capture phase, detecting phase and reagent containing them
BIO MERIEUX14 citations81
US6660533B2Dec 9, 2003
Attaching a biological molecule to a support surface
BIO MERIEUX13 citations79
US6184025B1Feb 6, 2001
Viral isolates associated with multiple sclerosis
BIO MERIEUX8 citations73
US5962217AOct 5, 1999
MSRV1 virus and MSRV2 pathogen and/or infective agent associated with multiple sclerosis, and biopolymer constituents thereof
BIO MERIEUX7 citations73
US5871996AFeb 16, 1999
Retrovirus agents MSRV1 and MSRV2 associated with multiple sclerosis
BIO MERIEUX6 citations73
US5871745AFeb 16, 1999
Multiple sclerosis related virus
BIO MERIEUX7 citations73
US5817465AOct 6, 1998
RNA amplification method requiring only one manipulation step
BIO MERIEUX8 citations72
US6828127B2Dec 7, 2004
Method of amplifying an RNA target sequence using an RNA polymerase functioning preferably on RNA template
BIO MERIEUX0 citations45
BIOMERIEUX SA
8 patentsUSRE39031EMar 21, 2006
RNA amplification method requiring only one manipulation step
BIOMERIEUX SA2 citations61
US11085091B2Aug 10, 2021
Method for in vitro diagnosis or prognosis of testicular cancer
BIOMERIEUX SA0 citations55
US7442550B1Oct 28, 2008
Method for detecting the expression of an envelope protein of a human endogenous retrovirus and uses of a gene coding for said protein
BIOMERIEUX SA3 citations53
US7771927B1Aug 10, 2010
Multiple sclerosis-associated retroviral (MSRV) nucleic acids corresponding to the Env region
BIOMERIEUX SA0 citations48
US10240213B2Mar 26, 2019
Method for in vitro diagnosis or prognosis of testicular cancer
BIOMERIEUX SA0 citations45
US7632931B2Dec 15, 2009
Endogeneous nucleic acid fragment associated with an autoimmune disease, labeling method and reagent
BIOMERIEUX SA1 citations45
US7595180B2Sep 29, 2009
RNA-dependent RNA polymerase functioning preferably on a RNA matrix and promoter-dependent transcription process with said RNA-dependent RNA polymerase
BIOMERIEUX SA0 citations45
US10040829B2Aug 7, 2018
Methods for producing peptides including HERV-W envelope motifs and for producing antibodies specific for the peptides
BIOMERIEUX SA0 citations44